| 慢性前列腺炎症状指数的临床应用 |
| |
| 引用本文： | 谢续标,彭龙开,赵晓昆. 慢性前列腺炎症状指数的临床应用[J]. 中国现代医学杂志, 2004, 14(15): 36-38 |
| |
| 作者姓名： | 谢续标 彭龙开 赵晓昆 |
| |
| 作者单位： | 中南大学湘雅二医院,泌尿外科,湖南,长沙,410011 |
| |
| 摘 要： | 目的采用美国国立卫生研究所(NIH)制定的慢性前列腺炎症状指数(CPSI)评估特拉唑嗪治疗慢性前列腺炎/慢性盆腔疼痛综合症(CPPS)的临床疗效.方法应用特拉唑嗪2～4 mg治疗CPPS 68例,疗程6周.采用NIH-CPSI对治疗结果进行评估.结果用药6周后,CPSI分值平均下降了16.6分(P＜0.01).结论特拉唑嗪是治疗CPPS的有效药物,与炎症性CPPS比较,特拉唑嗪治疗非炎症性CPPS效果更好.
|
| 关 键 词： | 前列腺炎 慢性前列腺炎症状指数 肾上腺素能α受体阻滞剂 治疗 α receptor blockader |
Clinical use of chronic prostatitis symptom index |
| |
| Abstract. Clinical use of chronic prostatitis symptom index[J]. China Journal of Modern Medicine, 2004, 14(15): 36-38 |
| |
| Authors: | Abstract |
| |
| Abstract: | Objective: To verify the clinical effects of terazosin on chronic prostatitis/chronic pelvic pain syndrome (CPPS).Methods:68 cases of CPPS were treated with 2 to 4 mg terazosin daily for 6 weeks, and its effects was evaluated by the chronic prostatitis symptom index (CPSI).Results: 6 weeks after administration, CPSI scores decreased by 16.6 ( P <0.01). Conclusions:It suggests that terazosin is effective for CPPS, and it is more effective to noninflammatory CPPS than to inflammatory CPPS. |
| |
| Keywords: | prostatitis chronic prostatitis symptom index therapy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
